Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial

Table 2

Comparison of the changes of the NIHSS and mRS scores between 2 groups at admission and 3 months after stroke.

Variable	ALC group ()	Placebo group ()	value
Admission NIHSS score,		12.26 ± 5.03	0.45
3-month after-stroke NIHSS score,			0.02
NIHSS alteration from admission to 3 months after stroke,			0.002
Admission mRS score,			0.62
3-month after-stroke mRS score,			0.02
mRS alteration from baseline to 3 months after stroke,			0.002

Note: ALC = acetyl-L-carnitine; NIHSS = National Institutes of Health Stroke Scale; mRS = modified Rankin Scale. The significant value is shown in bold type.